Rathbone Brothers plc lifted its stake in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 7.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,060 shares of the company’s stock after acquiring an additional 400 shares during the period. Rathbone Brothers plc’s holdings in Tabula Rasa HealthCare were worth $342,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the stock. Eqis Capital Management Inc. raised its stake in shares of Tabula Rasa HealthCare by 3.2% in the 4th quarter. Eqis Capital Management Inc. now owns 6,156 shares of the company’s stock valued at $392,000 after acquiring an additional 193 shares in the last quarter. Louisiana State Employees Retirement System raised its stake in shares of Tabula Rasa HealthCare by 3.0% in the 1st quarter. Louisiana State Employees Retirement System now owns 6,600 shares of the company’s stock valued at $372,000 after acquiring an additional 193 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in Tabula Rasa HealthCare by 3.3% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,019 shares of the company’s stock valued at $340,000 after buying an additional 194 shares during the last quarter. State of Alaska Department of Revenue grew its holdings in Tabula Rasa HealthCare by 4.2% in the 4th quarter. State of Alaska Department of Revenue now owns 5,676 shares of the company’s stock valued at $361,000 after buying an additional 231 shares during the last quarter. Finally, Comerica Bank grew its holdings in Tabula Rasa HealthCare by 1.4% in the 4th quarter. Comerica Bank now owns 16,519 shares of the company’s stock valued at $934,000 after buying an additional 235 shares during the last quarter. 82.79% of the stock is currently owned by institutional investors and hedge funds.
In other news, CEO Calvin H. Knowlton sold 8,270 shares of Tabula Rasa HealthCare stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $53.68, for a total transaction of $443,933.60. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Orsula V. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $58.10, for a total value of $464,800.00. The disclosure for this sale can be found here. Insiders have sold a total of 48,270 shares of company stock worth $2,565,774 in the last three months. 14.00% of the stock is owned by insiders.
A number of analysts have issued reports on TRHC shares. BidaskClub lowered Tabula Rasa HealthCare from a “hold” rating to a “sell” rating in a report on Friday, January 25th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $99.00 target price on shares of Tabula Rasa HealthCare in a report on Thursday, February 28th. Oppenheimer lowered their target price on Tabula Rasa HealthCare from $97.00 to $88.00 and set an “outperform” rating on the stock in a report on Wednesday, March 6th. First Analysis raised Tabula Rasa HealthCare from an “outperform” rating to a “strong-buy” rating and set a $58.33 target price on the stock in a report on Monday, March 11th. Finally, Guggenheim started coverage on Tabula Rasa HealthCare in a report on Wednesday, April 17th. They issued a “neutral” rating and a $58.00 target price on the stock. Five investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $82.12.
Shares of NASDAQ:TRHC opened at $43.83 on Friday. Tabula Rasa HealthCare Inc has a 1-year low of $42.29 and a 1-year high of $91.16. The company has a market cap of $963.73 million, a PE ratio of 128.91 and a beta of 1.51. The company has a current ratio of 1.80, a quick ratio of 1.73 and a debt-to-equity ratio of 1.31.
Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings data on Wednesday, May 8th. The company reported ($0.14) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.14). Tabula Rasa HealthCare had a positive return on equity of 4.22% and a negative net margin of 18.15%. The company had revenue of $60.96 million for the quarter, compared to analyst estimates of $59.24 million. Research analysts expect that Tabula Rasa HealthCare Inc will post -0.55 EPS for the current year.
WARNING: This article was originally posted by Zolmax and is the sole property of of Zolmax. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://zolmax.com/investing/tabula-rasa-healthcare-inc-trhc-position-lifted-by-rathbone-brothers-plc/3095044.html.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.
Featured Story: How do CD ladders protect against rising interest rates?
Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.